Clinical trial · Expanded Access
Compassionate Use of Ubamatamab
NCT07502716CI-TRIAL-00106894availableClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Provide Compassionate Use of Ubamatamab
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Epithelioid Sarcoma | Epithelioid Sarcoma | ONTOLOGY_EXACT | 0.90 |
| Renal Medullary Carcinoma (RMC) | Renal Medullary Carcinoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| ubamatamab | Drug | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
Show eligibility criteria text
Eligibility will be determined during the application review process.
References
Publications (0)
Data not yet available
No reference posted for this study.